These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

612 related items for PubMed ID: 12006367

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients.
    Miyazaki Y, Glass L, Triplitt C, Matsuda M, Cusi K, Mahankali A, Mahankali S, Mandarino LJ, DeFronzo RA.
    Diabetologia; 2001 Dec; 44(12):2210-9. PubMed ID: 11793023
    [Abstract] [Full Text] [Related]

  • 3. Effects of recombinant human IGF-I/IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetes.
    Saukkonen T, Shojaee-Moradie F, Williams RM, Amin R, Yuen KC, Watts A, Acerini CL, Umpleby AM, Dunger DB.
    Diabetes; 2006 Aug; 55(8):2365-70. PubMed ID: 16873702
    [Abstract] [Full Text] [Related]

  • 4. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.
    Groop LC, Bonadonna RC, DelPrato S, Ratheiser K, Zyck K, Ferrannini E, DeFronzo RA.
    J Clin Invest; 1989 Jul; 84(1):205-13. PubMed ID: 2661589
    [Abstract] [Full Text] [Related]

  • 5. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, Buzzigoli E, Sironi AM, Cersosimo E, Ferrannini E, Defronzo RA.
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [Abstract] [Full Text] [Related]

  • 6. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis.
    Boden G, Cheung P, Stein TP, Kresge K, Mozzoli M.
    Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E12-9. PubMed ID: 12067837
    [Abstract] [Full Text] [Related]

  • 7. Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans.
    Hussain MA, Schmitz O, Mengel A, Keller A, Christiansen JS, Zapf J, Froesch ER.
    J Clin Invest; 1993 Nov; 92(5):2249-56. PubMed ID: 8227340
    [Abstract] [Full Text] [Related]

  • 8. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
    Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, DeFronzo RA.
    J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032
    [Abstract] [Full Text] [Related]

  • 9. Co-administration of etomoxir and RU-486 mitigates insulin resistance in hepatic and muscular tissues of STZ-induced diabetic rats.
    Bitar MS.
    Horm Metab Res; 2001 Oct; 33(10):577-84. PubMed ID: 11607876
    [Abstract] [Full Text] [Related]

  • 10. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
    Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Järvinen H.
    Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
    [Abstract] [Full Text] [Related]

  • 11. Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis.
    Petrides AS, Groop LC, Riely CA, DeFronzo RA.
    J Clin Invest; 1991 Aug; 88(2):561-70. PubMed ID: 1864966
    [Abstract] [Full Text] [Related]

  • 12. Quantitation of forearm glucose and free fatty acid (FFA) disposal in normal subjects and type II diabetic patients: evidence against an essential role for FFA in the pathogenesis of insulin resistance.
    Capaldo B, Napoli R, Di Marino L, Picardi A, Riccardi G, Sacca L.
    J Clin Endocrinol Metab; 1988 Nov; 67(5):893-8. PubMed ID: 3053749
    [Abstract] [Full Text] [Related]

  • 13. Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta.
    Lam TK, Yoshii H, Haber CA, Bogdanovic E, Lam L, Fantus IG, Giacca A.
    Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E682-91. PubMed ID: 12217885
    [Abstract] [Full Text] [Related]

  • 14. Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes.
    Bajaj M, Suraamornkul S, Kashyap S, Cusi K, Mandarino L, DeFronzo RA.
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4649-55. PubMed ID: 15356076
    [Abstract] [Full Text] [Related]

  • 15. Sulfonylurea therapy fails to diminish insulin resistance in type I-diabetic subjects.
    Keller U, Müller R, Berger W.
    Horm Metab Res; 1986 Sep; 18(9):599-603. PubMed ID: 2946637
    [Abstract] [Full Text] [Related]

  • 16. Insulin sensitivity of blood glucose versus insulin sensitivity of blood free fatty acids in normal, obese, and obese-diabetic subjects.
    Belfiore F, Iannello S, Camuto M, Fagone S, Cavaleri A.
    Metabolism; 2001 May; 50(5):573-82. PubMed ID: 11319720
    [Abstract] [Full Text] [Related]

  • 17. The effect of the -308A allele of the TNF-alpha gene on insulin action is dependent on obesity.
    Pihlajamäki J, Ylinen M, Karhapää P, Vauhkonen I, Laakso M.
    Obes Res; 2003 Jul; 11(7):912-7. PubMed ID: 12855762
    [Abstract] [Full Text] [Related]

  • 18. Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes.
    Simpson HL, Jackson NC, Shojaee-Moradie F, Jones RH, Russell-Jones DL, Sönksen PH, Dunger DB, Umpleby AM.
    J Clin Endocrinol Metab; 2004 Jan; 89(1):425-32. PubMed ID: 14715881
    [Abstract] [Full Text] [Related]

  • 19. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
    Golay A, Defronzo RA, Thorin D, Jequier E, Felber JP.
    Diabete Metab; 1988 Jan; 14(4):443-51. PubMed ID: 3066652
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans.
    Laager R, Ninnis R, Keller U.
    J Clin Invest; 1993 Oct; 92(4):1903-9. PubMed ID: 8408642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.